From 10th to 12th September 2013, the European Commission travelled to Brazil with a selection of 9 European, life science clusters and four SMEs. The mission’s objective was to foster bilateral exchanges at different levels between European and Brazilian partners. To this end, the mission was organised around the BioPartnering Latin America event. Continue reading
Until recently, the history of the pharmaceutical industry in China was more about imitation than innovation.
According to a report by London-based market researcher Scrip Intelligence, approximately 40% of biotech sales in China come from biosimilars. This would explain why the market for biologics in China has been growing at a rate of more than 25% a year, while total sales of biotech drugs are still only $1.5 billion a year. Read more
The BioXclusters partners are preparing next year’s calendar and China is one of their priorities. Amongst the different activities planned, we are organising a visit to the four regions by a Chinese expert in January as well as a mission to the country in May. Continue reading